Sperger and Fiksdahl
JOCArticle
(35 mg, 0.154 mmol) in DCM (c = 500 mM) for 18 h. Flash
chromatography (DCM/ethanol 96:4) provided a mixture of
26b and 27b (19.5 mg, 56%, 26b/27b 10:90) as a pale yellow oil.
26b and 27b: Rf=0.67 (DCM/methanol 4:1). As it was not pos-
sible to separate 26b and 27b, detailed analytical data could not
be obtained. (See 1H NMR and NOESY spectra of mixture).
(E)-(()-Methyl 3-(But-2-ynyl)-5-ethylidene-2-oxotetrahydro-
3-carboxylate (28), Methyl 3-(But-2-ynyl)-6-methyl-2-oxo-3,4-
dihydro-2H-pyran-3-carboxylate (29), and (()-Methyl 6-Ethyli-
dene-4-methylene-2-oxo-3-oxabicyclo[3.2.1]octane-1-carboxylate
(30). Representative Procedure I. (Table 2, entry 10) The title
compounds were prepared according to the general procedure
from AuCl(IMes) (2.42 mg, 4.5 μmol, 2.0 mol %), AgNTf2
(1.75 mg, 4.5 μmol, 2.0 mol %) and 11 (50 mg, 0.225 mmol) in
DCM (c=500 mM) for 18 h. Flash chromatography (n-hexane/
EtOAc 12:1) provided 28 (7.1 mg, 14%) as a colorless oil and 30
(16.3 mg, 33%) as a colorless oil.
from catalyst A (2.32 mg, 3.0 μmol, 2.5 mol %), NEt3 (0.30 mg,
3.0 μmol, 0.42 μL, 5.0 mol %), and 12 (30 mg, 0.120 mmol) in
refluxing DCM (c = 500 mM) for 6 h. Flash chromatography
(n-hexane/EtOAc 4:1) provided a mixture of 34 and 35 (26.3 mg,
88%, 34/35 18:82) as a colorless oil. A pure sample of 35 was
obtained by HPFP (23 ꢀ 110 mm, 23 g SiO2, n-hexane/EtOAc
10:1).
1
31: Rf = 0.26 (n-hexane/EtOAc 1:1); H NMR (300 MHz,
CDCl3) δ 1.13 (t, J=7.2 Hz, 3 H, CH2CH3), 1.68 (dt, J=6.9/
1.1 Hz, 3 H, CH3), 1.70 (t, J=2.6 Hz, 3 H, CH3), 2.76-2.80 (m,
2 H, CH2), 2.79-2.89 (m, 1 H, H-4), 3.04-3.13 (m, 1 H, H-4),
3.39-3.52 (m, 1 H, CH2CH3), 3.57-3.70 (m, 1 H, CH2CH3),
3.74 (s, 3 H, OCH3), 4.78 (qt, J = 6.8/2.3 Hz, 1 H, CH); 13C
NMR (100 MHz, CDCl3) δ 3.5 (CH3), 11.7 (CH2CH3), 11.9
(CH3), 24.7 (CH2), 31.9 (C-4), 35.2 (CH2CH3), 53.0 (C-3), 54.0
(OCH3), 73.5 (Calkyne), 78.3 (Calkyne), 95.0 (CH), 136.2 (C-5),
171.2 (CO), 171.5 (CO); IR (neat, cm-1) 2954, 1744, 1707, 1677,
1417, 1250; HRMS (ESI) calcd for C14H20NO3 250.1443,
Representative Procedure II. (Table 2, entry 14) The title
compounds were prepared according to the general proced-
ure from AuCl3 (2.05 mg, 6.8 μmol, 5.0 mol %) and 11 (30 mg,
0.135 mmol) in DCM (c=500 mM) for 2 h. The crude reaction
mixture was purified using a VersaFlash purification system
(23 ꢀ 110 mm, 23 g SiO2, n-hexane/EtOAc 12:1) to yield 28
(6.3 mg, 21%) as a colorless oil and 29 (6.0 mg, 20%) as a
colorless oil.
1
obsd 250.1440. 34: Rf = 0.35 (n-hexane/EtOAc 1:1); H NMR
(300 MHz, CDCl3) δ 1.09 (t, J = 6.8 Hz, 3 H, CH2CH3),
1.66-1.73 (m, 3 H, CH3), 1.94 (dd, J = 11.5/4.9 Hz, 1 H,
H-8), 2.36 (dd, J = 11.5/1.9 Hz, 1 H, H-8), 2.70-2.79 (m, 1 H,
H-7), 2.84-2.95 (m, 1 H, H-7), 2.57-3.75 (m, 3 H, CH2CH3 þ
H-5), 3.78 (s, 3 H, OCH3), 4.19 (s, 2 H, CCH2), 5.43 (qm, J=6.8
Hz, 1 H, CH). As a pure sample of 34 could not be obtained only
1
1
28: Rf = 0.56 (n-hexane/EtOAc 1:1); H NMR (300 MHz,
the H NMR datas are given. 35: Rf = 0.35 (n-hexane/EtOAc
1
CDCl3) δ 1.71 (dt, J=6.8/1.9 Hz, 3 H, CH3), 1.75 (t, J=2.6 Hz,
3 H, CCH3), 2.80-2.85 (m, 2 H, CH2C), 3.09-3.18 (m, 1 H,
H-4), 3.18-3.27 (m, 1 H, H-4), 3.78 (s, 3 H, OCH3), 4.70 (qt, J=
6.8/1.9 Hz, 1 H, CH); 13C NMR (75 MHz, CDCl3) δ 3.4 (CH3),
10.4 (CH3), 24.3 (CH2), 34.6 (C-4), 53.4 (C-3), 54.6 (OCH3), 72.4
(Calkyne), 79.7 (Calkyne), 99.9 (CH), 145.4 (C-5), 169.0 (CO),
171.9 (CO); IR (neat, cm-1) 2954, 1738, 1716, 1435, 1198.
HRMS (ESI) calcd for C12H15O4 223.0970, obsd 223.0967. 29:
Rf = 0.52 (n-hexane/EtOAc 1:1); 1H NMR (300 MHz, CDCl3)
δ 1.77 (t, J = 2.6 Hz, 3 H, CH3), 1.86-1.89 (m, 3 H, CH3),
2.56-2.67 (m, 1 H, H-4), 2.69-2.81 (m, 2 H, CH2, H-4 þ
CH2CC), 2.86 (dq, J = 16.6/2.6 Hz, 1 H, CH2CC), 3.76 (s,
3 H, OCH3), 4.98-5.04 (m, 1 H, H-5); 13C NMR (75 MHz,
CDCl3) δ 3.6 (CH3), 18.4 (CH3), 24.8 (CH2), 27.5 (C-4), 52.2
(OCH3), 53.2 (C-3), 73.1 (Calkyne), 79.3 (Calkyne), 99.1 (C-5),
149.8 (C-6), 166.8 (CO), 170.0 (CO); IR (neat, cm-1) 2955, 2923,
1796, 1772, 1737, 1716, 1435, 1146; HRMS (ESI) calcd for
C12H15O4 223.0970, obsd 223.0969. 30: Rf = 0.51 (n-hexane/
EtOAc 1:1); 1H NMR (300 MHz, CDCl3) δ 1.74-1.78 (m, 3 H,
CH3), 1.98 (dd, J = 12.4/3.5 Hz, 1 H, H-9), 2.47 (dd, J = 12.4/
2.3 Hz, 1 H, H-9), 2.53-2.65 (m, 1 H, H-8), 2.74-2.85 (m, 1 H,
H-8), 2.97 (dd, J = 3.5/2.3 Hz, 1 H, H-5), 3.78 (s, 3 H, OCH3),
4.36 (d, J=1.6 Hz, 1 H, CCH2), 4.64 (d, J=1.6 Hz, 1 H, CCH2),
5.53-5.59 (m, 1 H, H-7); 13C NMR (75 MHz, CDCl3) δ 21.0
(CH3), 30.2 (C-9), 34.7 (C-8), 38.7 (C-5), 50.2 (C-1), 53.0
(OCH3), 92.7 (CH2), 121.1 (C-7), 132.6 (C-6), 155.9 (C-4),
168.4 (CO), 170.9 (CO); IR (neat, cm-1) 2954, 1741, 1658,
1271, 1225, 1054; HRMS (ESI) calcd for C12H15O4 223.0970,
obsd 223.0967.
1:1); H NMR (400 MHz, CDCl3) δ 1.08 (t, J = 7.1 Hz, 3 H,
CH2CH3), 1.70-1.73 (m, 3 H, CH3), 1.90 (dd, J=12.1/3.4 Hz,
1 H, H-9), 2.42-2.47 (m, 1 H, H-9), 2.50-2.59 (m, 1 H, H-7),
2.66-2.74 (m, 1 H, H-7), 2.86-2.90 (m, 1 H, H-5), 3.72 (q, J=
7.1 Hz, 2 H, CH2CH3), 3.75 (s, 3 H, OCH3), 4.30 (d, J=1.1 Hz,
1 H, CCH2), 4.32 (d, J=1.1 Hz, 1 H, CCH2), 5.44-5.49 (m, 1 H,
H-7); 13C NMR (100 MHz, CDCl3) δ 11.6 (CH2CH3), 21.0
(CH3), 31.0 (C-9), 33.7 (C-8), 37.5 (CH2CH3), 41.9 (C-4), 50.8
(OCH3), 52.5 (C-1), 91.0 (CH2), 120.8 (C-7), 133.4 (C-6), 144.8
(C-4), 169.1 (CON), 172.7 (CO); IR (neat, cm-1) 2956, 1739,
1673, 1620, 1230; HRMS (ESI) calcd for C14H20NO3 250.1443,
obsd 250.1436.
(()-Methyl 6-Methyl-4-methylene-2-oxo-3-azabicyclo[3.3.1]-
non-6-ene-1-carboxylate (36). Representative Procedure. (Table 3,
entry 7) The title compound was prepared according to the general
procedure from catalyst A (8.73 mg, 11.3 μmol, 5 mol %) and 14
(50 mg, 0.226 mmol) in DCM (c = 500 mM) for 4 h at room
temperature. Flash chromatography (n-hexane/EtOAc 1:1) pro-
vided 36 (16.2 mg, 32%) as a colorless solid. Rf =0.24 (n-hexane/
EtOAc 1:1); mp 123-126 °C; 1H NMR (300 MHz, CDCl3)
δ 1.72-1.75 (m, 3 H, CH3), 1.94 (dd, J = 12.6/3.4 Hz, 1 H,
H-9), 2.41-2.48 (m, 1 H, H-9), 2.48-2.59 (m, 1 H, H-8), 2.71-2.82
(m, 1 H, H-8), 2.83-2.89 (m, 1 H, H-5), 3.76 (s, 3 H, OCH3), 4.19
(s, 1 H, CCH2), 4.23 (s, 1 H, CCH2), 5.44-5.50 (m, 1 H, H-7), 7.69
(s, 1 H, NH); 13C NMR (100 MHz, CDCl3) δ 21.1 (CH3), 30.6
(C-9), 33.0 (C-8), 39.4 (C-5), 49.6 (OCH3), 52.6 (C-1), 90.8 (CH2),
120.5 (C-7), 133.2 (C-6), 142.7 (C-4), 170.5 (CONH), 172.2 (CO);
IR (neat, cm-1) 3180, 1739, 1655, 1234; HRMS (ESI) calcd for
C12H16NO3 222.1130, obsd 222.1123.
(E)-Methyl 3-(But-2-ynyl)-1-ethyl-5-ethylidene-2-oxopyrroli-
dine-3-carboxylate (31), (Z)-Methyl 3-Ethyl-6-ethylidene-4-methy-
lene-2-oxo-3-azabicyclo[3.2.1]octane-1-carboxylate (34), and Methyl
3-Ethyl-6-methyl-4-methylene-2-oxo-3-azabicyclo[3.3.1]non-6-ene-
1-carboxylate (35). Representative Procedure I. (Table 3, entry
6) The title compounds were prepared according to the general
procedure from AuCl(PPh3) (3.72 mg, 8.0 μmol, 5.0 mol %),
AgNTf2 (3.11 mg, 8.0 μmol, 5.0 mol %), NEt3 (0.81 mg, 8.0 μmol,
1.12 μL, 5.0 mol %), and 12 (40 mg, 0.160 mmol) in refluxing
DCM (c=500 mM) for 6 h. Flash chromatography (n-hexane/
EtOAc 4:1) yielded 31 (21.8 mg, 55%) as a colorless oil.
Dimethyl 2-(But-2-ynyl)-2-((1-(ethylimino)-1H-isochromen-3-
yl)methyl)malonate (37). Representative Procedure. (Table 4,
entry 3) The title compound was prepared according to the
general procedure from catalyst A (3.14 mg, 4.1 μmol, 5 mol %)
and 22 (30 mg, 0.08 mmol) in toluene (c=250 mM) at 90 °C for
20 h. Flash chromatography (n-hexane/EtOAc 4:1) provided 37
(17.7 mg, 59%) as a colorless oil. Rf = 0.35 (n-hexane/EtOAc
1
1:1); H NMR (300 MHz, CDCl3) δ 1.26 (t, J = 7.5 Hz, 3 H,
CH2CH3), 1.80 (t, J=2.6 Hz, 3 H, CH3), 2.86 (q, J=2.6 Hz, 2 H,
CH2), 3.20 (s, 2 H, CH2), 3.45 (q, J=7.5 Hz, 2 H, CH2CH3), 3.76
(s, 6 H, OCH3), 5.99 (s, 1 H, CH), 7.11 (dd, J=7.9/1.1 Hz, 1 H,
Representative Procedure II. (Table 3, entry 6) The title
compounds were prepared according to the general procedure
H
arom), 7.25-7.32 (m, 1 H, Harom), 7.38-7.44 (m, 1 H, Harom),
8.03-8.13 (m, 1 H, Harom); 13C NMR (75 MHz, CDCl3) δ 3.5
4552 J. Org. Chem. Vol. 75, No. 13, 2010